HR 3491: DeOndra Dixon INCLUDE Project Act of 2025

HR 3491 in plain English: This bill gives permanent statutory authority to an existing NIH program focused on Down syndrome research and training, including research on related health conditions and quality-of-life improvements. The NIH must consult stakeholders, avoid duplicating existing research, and report to Congress every two years on findings.

Stated purpose

This bill gives permanent legal authorization to an existing NIH program dedicated to research, training, and investigation related to Down syndrome, including its co-occurring conditions and improving quality of life for people with Down syndrome across their lifespan.

Key points

• Grants formal legal authority to an existing NIH program on Down syndrome research and training.
• Requires NIH to study co-occurring conditions and ways to improve quality of life for people with Down syndrome.
• Mandates NIH consult relevant stakeholders and avoid duplicating existing Down syndrome research.
• Requires NIH to submit a report to Congress every two years cataloging research results.

Arguments supporters make

• Giving the INCLUDE Project permanent legal standing protects it from being eliminated by future budget or administrative changes, providing more stable, long-term research for a community that has historically had limited options.
• The bill addresses serious health challenges common in people with Down syndrome, such as Alzheimer's disease and autoimmune conditions, which could lead to treatments that meaningfully improve and extend their lives.
• Built-in requirements to avoid duplicating existing research and to consult patient advocates help ensure NIH spends resources wisely and stays focused on what actually matters to affected individuals and families.

Arguments opponents make

• Codifying a specific disease program into law limits Congress's and NIH's flexibility to shift research priorities as scientific needs evolve or as funding becomes constrained across many competing health conditions.
• The bill does not authorize or appropriate any specific funding, so it may create a legal mandate without guaranteeing the money needed to carry it out effectively.
• Critics may argue that directing NIH through legislation to focus on one condition sets a precedent where every disease community seeks its own statutory program, potentially fragmenting the agency's ability to set research priorities based on science alone.

Tradeoffs

Permanently authorizing this program gives the Down syndrome community more durable research support, but reduces administrative flexibility for NIH to reallocate resources across health priorities. The bill establishes clear obligations for coordination and reporting, but leaves funding levels to the separate appropriations process, meaning the mandate and the money may not align.

Current status in Congress: Passed House.

NewsClear — neutral news & congressional tracking · Bill of the Week